As of June 4, 2025, Bio-View Ltd (BIOV.TA) reports a Net Margin of -12.27%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Bio-View Ltd's Net Margin
Over recent years, Bio-View Ltd's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-12-31 | -12.27% |
| 2023-12-31 | 1.10% |
| 2022-12-31 | 2.01% |
| 2021-12-31 | 7.16% |
| 2020-12-31 | 3.41% |
This slight downward trend highlights how Bio-View Ltd manages its overall profitability and cost control over time.
Comparing Bio-View Ltd's Net Margin to Peers
To better understand Bio-View Ltd's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Bio-View Ltd (BIOV.TA) | -12.27% |
| Elbit Imaging Ltd (EMITF.TA) | 3885.24% |
| Elbit Medical Technologies Ltd (EMTC.TA) | 91.05% |
| Allmed Solutions Ltd (ALMD.TA) | 50.64% |
| Sisram Medical Ltd (1696.HK) | 7.20% |
| Endymed Ltd (ENDY.TA) | 2.43% |
Compared to its competitors, Bio-View Ltd's Net Margin is about average compared to peers, reflecting typical industry profitability.